Home » Healthcare » Pharmaceuticals » Porokeratosis Market

Porokeratosis Market By Therapies (Topical 5- fluorouracil, Topical Vitamin D, Imiquimod, Retinoids, Cryotherapy, Laser Therapy, Others) By End-User (Hospitals, Clinics, Diagnostic Centres, Research and academic Institutes) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2028

Summary
Table Of Content

About this report

The Global Porokeratosis Market report explores the critical analysis of the Porokeratosis industry using key parameters. The report consists of investment strategies, the need for investments in the Porokeratosis industry, and the multiple benefits for the investors. Importantly, this report sets out major changes in the global technical regulations for the Porokeratosis industry, as well as how economic and non-economic barriers are helping the Porokeratosis market. Moreover, the report analyses the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses such as porter’s five forces analysis, PESTEL analysis, value chain analysis, etc.

Key Highlights of the report

How are the major segments performing in the Porokeratosis Market?

In 2021, laser therapy will be the leading segment based on therapies owing to the appealing elements of laser therapy, such as the lack of an incision and the absence of hospitalization. The use of laser therapy to treat porokeratosis is gaining favor.
In 2021, the hospital segment will lead the market because of increased government financing, greater disposable income, and growing health concerns.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Which region dominated the Porokeratosis Market?

In 2021, North America was one of the major contributors to the global porokeratosis market. Because porokeratosis affects 10% of kidney patients, the number of cases is increasing as more than 660,000 Americans have kidney failure, and 467,000 are on dialysis. Therefore, due to the rising incidence of diffused superficial actinic porokeratosis and rising renal transplant rates, approximately 10.68% of people who received kidney transplants also had porokeratosis. In addition, the presence of major players has increased healthcare spending, and enhanced diagnostic and therapeutic options are anticipated to drive the American porokeratosis treatment market.

What is the competitive environment of the Porokeratosis Market?

Porokeratosis treatment manufacturers are implementing several expansion strategies to increase their market shares in the global porokeratosis markets. For instance, Chugai and Galderma formed an international licensing agreement for the development and marketing of Nemolizumab. Key players are investing in developing and marketing a better, more cost-effective solution for the porokeratosis market, particularly in emerging economies where minimal aesthetic spending occurs. The market is seeing an influx of innovations, and most are quickly gaining popularity. The high desire for treatments that produce quick results and involve patients for a little time is expected to restrict the market for porokeratosis. Regular product innovation presents a wide range of possibilities for reducing treatment costs.

Executive Summary

What are the effects of porokeratosis?

Porokeratosis is a group of skin conditions frequently manifest as tiny patches with a raised border. The term “porokeratosis” refers to a variety of skin conditions wherein the affected area develops pink, red, or brown pimples with a raised edge. Porokeratosis occasionally affects just one area or manifests itself in multiple locations. Porokeratosis has six basic kinds that differ in size, color, and where they manifest on the body. Porokeratosis typically no longer raises safety concerns. However, there is a chance that malignant cells could potentially develop in the afflicted locations. Porokeratosis is no longer communicable, and although it may also worsen in some areas, it is unlikely to spread by touch. Porokeratosis is a precancerous condition with the potential for the cells to transform into cancer in all of its variants radically.

Which are the key investments by the players in the Porokeratosis Industry Market?

Major businesses vigorously invest in better and more efficient therapies as funding for porokeratosis increases. As financing for porokeratosis therapy rises, there is fierce competition among the top providers, which leads to an increase in product introductions. A better and more affordable remedy is being developed and marketed by major businesses for the porokeratosis market.

Some of the major players in the market are Coherent Inc., Alma Lasers, Almirall, Allergan, Pfizer, Lumenis, Coty Inc., Cutera, Bioness Inc., Biogen, PhotoMedex Inc., Valeant Pharmaceuticals, Hologic Inc., IPG Photonics Corporation, IRIDEX Corp., Hoffman-La Roche Ltd., Biolase Inc., Angiodynamics Inc. and Beiersdorf AG, etc.

What are the Major Driving Factors for the Porokeratosis Market?

The global porokeratosis market will grow for various reasons, such as rising laser therapy demand, increased kidney transplant cases, better reimbursement laws in developed countries, rising research expenses, and rising competition among market traders. The porokeratosis market is rising because of the growing awareness of the condition and the demand for better skin. If more worldwide treatment ideas are communicated, consumers are more likely to adopt porokeratosis therapy products and procedures. Consumer awareness of the disease’s malignant development is growing in industrialized nations. The market for porokeratosis will grow in response to the increased demand for personal care products. Clinical observation is sufficient to understand the malignant development of porokeratosis. The need for porokeratosis therapies has surged due to this raised awareness.

What are the Major Risks for the Porokeratosis Market?

The high cost of laser equipment, a lack of skilled or trained physicians, pharmacological side effects, and a bad healthcare system in low and middle-income nations may stymie market expansion. Porokeratosis is also a rare condition; thus, there is minimal awareness worldwide, which is a significant barrier for the market.

Which are the Key Therapies in the Porokeratosis Market?

Porokeratosis has a variety of potential treatments, including topical 5-fluorouracil, topical vitamin D, imiquimod, retinoids, cryotherapy, laser therapy, and others. In 2021, laser therapy received much attention among all the methods used to treat porokeratosis. The adoption of laser therapy for porokeratosis treatment is increasing, which further fuels the market’s growth. This is due to the appealing aspects of laser therapy, such as the lack of incision and no hospitalization. Growing in popularity is the use of laser therapy to treat porokeratosis. The doctor removes the skin fragment using a laser device, allowing new skin to regenerate in its place. Patients with various types of porokeratosis were treated with laser therapy, and the results were encouraging. Consumers are increasingly choosing CO2 laser treatment since it is an easy, painless, and rapid process.

How is the Porokeratosis Market performing in regions?

In 2021, the global porokeratosis market was dominated by North America. The United States dominates the porokeratosis market because of the increased incidence of actinic porokeratosis and the rise in kidney transplant cases. 10.68% or so of kidney transplant recipients have porokeratosis. In the United States, approximately 17,000 kidney transplants were performed in 2019, according to the National Kidney Foundation, Inc. High-quality diagnostic and therapeutic options, significant health expenditures, and the presence of elite athletes are all expected to contribute to the expansion of the American medical market for porokeratosis.

Besides, the Asia Pacific market is expected to grow significantly over the forecast period with its expanding healthcare system and higher healthcare costs. Furthermore, a substantial proportion of the population in Japan is over the age of 65. Hence, the ailment is more common there. Asian countries have a higher prevalence of porokeratosis, like DSAP and Mibelli. The rise in cases is a result of a lack of awareness of the therapy among the populace; as a result, the government should take action to educate people in rural areas about the therapies, which might enhance the adoption of treatment.

What is the regulatory landscape for the Porokeratosis Market?

In developed countries, government backing and the installation of better reimbursement procedures have attracted a huge number of clients. Consumers are becoming more interested in aesthetics, particularly in wealthier countries, as disposable income and reimbursement rules increase. By raising awareness and implementing reimbursement regulations, the government can play a vital role in the porokeratosis market.

What is the Market Size of Porokeratosis regarding value?

The Porokeratosis Market is anticipated to grow at a substantial CAGR of 6.50% in the upcoming years. The Global Porokeratosis industry was estimated to be worth USD 1.6 billion in 2021 and was expected to be worth USD 2.3 billion by 2028.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

What effect does COVID-19 have on the market for porokeratosis?

The recession in global economic growth has also impacted the porokeratosis market, but it has continued to grow steadily. The pandemic has, however, resulted in fewer patients visiting the clinic’s doctors. The pandemic may prevent manufacturers from obtaining the chemicals in the same quantities. For the porokeratosis market, there are significant supply chain difficulties. Supply chain issues have significantly impacted the market for rare diseases like porokeratosis. However, it is anticipated that worries about health and the environment during the pandemic will have little effect on the expansion of the porokeratosis industry in the foreseeable future.

Segmentation of Global Porokeratosis Market-

Global Porokeratosis Market – By Therapies

Topical 5- fluorouracil
Topical Vitamin D
Imiquimod
Retinoids
Cryotherapy
Laser Therapy
Others

Global Porokeratosis Market – By End-User

Hospitals
Clinics
Diagnostic Centres
Research and academic Institutes

Global Porokeratosis Market – By Region

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global Porokeratosis Market
2.2. Global Porokeratosis Market, By Therapies
2.3. Global Porokeratosis Market, By End-User
2.4. Global Porokeratosis Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Porokeratosis Market Value, 2016-2028, (US$ Bn)
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Market Drivers
3.2.3. Market Restraints
3.2.4. Market Opportunities
3.2.5. Major Industry Challenges
3.3. Attractive Investment Proposition,2021
3.3.1. Therapies
3.3.2. End-User
3.3.3. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Value Chain Analysis
4.4. Therapies Analysis
4.5. Marketing Strategy Analysis
4.5.1. Direct Marketing
4.5.2. Indirect Marketing
4.5.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2021
5.1. Company market share of key players, 2021
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others
6. COVID 19 Impact Analysis
6.1. Global Porokeratosis Market Pre Vs Post COVID 19, 2019 – 2028
6.2. Impact on Import & Export
6.3. Impact on Demand & Supply

7. Global Porokeratosis Market
7.1. Global Porokeratosis Market, by Therapies, 2016-2028(US$ Bn)
7.1.1. Overview
7.1.2. Global Porokeratosis Market, By Therapies, 2021 vs 2028 (in%)
7.1.3. Global Porokeratosis Market, By Topical 5- fluorouracil, 2016-2028 (US$ Bn)
7.1.4. Global Porokeratosis Market, By Topical Vitamin D, 2016-2028 (US$ Bn)
7.1.5. Global Porokeratosis Market, By Imiquimod, 2016-2028 (US$ Bn)
7.1.6. Global Porokeratosis Market, By Retinoids, 2016-2028 (US$ Bn)
7.1.7. Global Porokeratosis Market, By Cryotherapy, 2016-2028 (US$ Bn)
7.1.8. Global Porokeratosis Market, By Laser Therapy, 2016-2028 (US$ Bn)
7.1.9. Global Porokeratosis Market, By Others, 2016-2028 (US$ Bn)
7.2. Global Porokeratosis Market, by End-User, 2016-2028(US$ Bn)
7.2.1. Overview
7.2.2. Global Porokeratosis Market, By End-User, 2021 vs 2028 (in%)
7.2.3. Global Porokeratosis Market, By Hospitals, 2016-2028 (US$ Bn)
7.2.4. Global Porokeratosis Market, By Clinics, 2016-2028 (US$ Bn)
7.2.5. Global Porokeratosis Market, By Diagnostic Centres, 2016-2028 (US$ Bn)
7.2.6. Global Porokeratosis Market, By Research and academic Institutes, 2016-2028 (US$ Bn)

8. North America Porokeratosis Market Analysis
8.1. North America Porokeratosis Market, by Therapies, 2016-2028(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Porokeratosis Market, by End-User, 2016-2028(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Porokeratosis Market, by Country, 2016-2028 (US$ Bn)
8.3.1. U.S.
8.3.1.1. U.S. Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.3.1.2. U.S. Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
8.3.1.3. U.S. Porokeratosis, By End-User, 2016-2028 (US$ Bn)
8.3.2. Canada
8.3.2.1. Canada Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.3.2.2. Canada Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
8.3.2.3. Canada Porokeratosis, By End-User, 2016-2028 (US$ Bn)

9. Europe Porokeratosis Market Analysis
9.1. Europe Porokeratosis Market, by Therapies, 2016-2028(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Porokeratosis Market, by End-User, 2016-2028(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Porokeratosis Market, by Country, 2016-2028 (US$ Bn)
9.3.1. Germany
9.3.1.1. Germany Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.3.1.2. Germany Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
9.3.1.3. Germany Porokeratosis, By End-User, 2016-2028 (US$ Bn)
9.3.2. France
9.3.2.1. France Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.3.2.2. France Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
9.3.2.3. France Porokeratosis, By End-User, 2016-2028 (US$ Bn)
9.3.3. UK
9.3.3.1. UK Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.3.3.2. UK Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
9.3.3.3. UK Porokeratosis, By End-User, 2016-2028 (US$ Bn)
9.3.4. Italy
9.3.4.1. Italy Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.3.4.2. Italy Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
9.3.4.3. Italy Porokeratosis, By End-User, 2016-2028 (US$ Bn)
9.3.5. Spain
9.3.5.1. Spain Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.3.5.2. Spain Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
9.3.5.3. Spain Porokeratosis, By End-User, 2016-2028 (US$ Bn)
9.3.6. Rest of Europe
9.3.6.1. Rest of Europe Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.3.6.2. Rest of Europe Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
9.3.6.3. Rest of Europe Porokeratosis, By End-User, 2016-2028 (US$ Bn)

10. Asia Pacific Porokeratosis Market Analysis
10.1. Asia Pacific Porokeratosis Market, by Therapies, 2016-2028(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Porokeratosis Market, by End-User, 2016-2028(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Porokeratosis Market, by Country, 2016-2028 (US$ Bn)
10.3.1. China
10.3.1.1. China Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.3.1.2. China Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
10.3.1.3. China Porokeratosis, By End-User, 2016-2028 (US$ Bn)
10.3.2. Japan
10.3.2.1. Japan Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.3.2.2. Japan Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
10.3.2.3. Japan Porokeratosis, By End-User, 2016-2028 (US$ Bn)
10.3.3. India
10.3.3.1. India Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.3.3.2. India Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
10.3.3.3. India Porokeratosis, By End-User, 2016-2028 (US$ Bn)
10.3.4. South Korea
10.3.4.1. South Korea Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.3.4.2. South Korea Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
10.3.4.3. South Korea Porokeratosis, By End-User, 2016-2028 (US$ Bn)
10.3.5. South-East Asia
10.3.5.1. South-East Asia Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.3.5.2. South-East Asia Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
10.3.5.3. South-East Asia Porokeratosis, By End-User, 2016-2028 (US$ Bn)
10.3.6. Rest of Asia Pacific
10.3.6.1. Rest of Asia Pacific Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.3.6.2. Rest of Asia Pacific Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
10.3.6.3. Rest of Asia Pacific Porokeratosis, By End-User, 2016-2028 (US$ Bn)

11. Latin America Porokeratosis Market Analysis
11.1. Latin America Porokeratosis Market, by Therapies, 2016-2028(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Porokeratosis Market, by End-User, 2016-2028(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Porokeratosis Market, by Country, 2016-2028 (US$ Bn)
11.3.1. Brazil
11.3.1.1. Brazil Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.3.1.2. Brazil Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
11.3.1.3. Brazil Porokeratosis, By End-User, 2016-2028 (US$ Bn)
11.3.2. Mexico
11.3.2.1. Mexico Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.3.2.2. Mexico Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
11.3.2.3. Mexico Porokeratosis, By End-User, 2016-2028 (US$ Bn)
11.3.3. Rest of Latin America
11.3.3.1. Rest of Latin America Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.3.3.2. Rest of Latin America Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
11.3.3.3. Rest of Latin America Porokeratosis, By End-User, 2016-2028 (US$ Bn)

12. Middle East and Africa Porokeratosis Market Analysis
12.1. Middle East and Africa Porokeratosis Market, by Therapies, 2016-2028(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Porokeratosis Market, by End-User, 2016-2028(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Porokeratosis Market, by Country, 2016-2028 (US$ Bn)
12.3.1. GCC Countries
12.3.1.1. GCC Countries il Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.3.1.2. GCC Countries Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
12.3.1.3. GCC Countries Porokeratosis, By End-User, 2016-2028 (US$ Bn)
12.3.2. South Africa
12.3.2.1. South Africa Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.3.2.2. South Africa Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
12.3.2.3. South Africa Porokeratosis, By End-User, 2016-2028 (US$ Bn)
12.3.3. Rest of Middle East and Africa
12.3.3.1. Rest of Middle East and Africa Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.3.3.2. Rest of Middle East and Africa Porokeratosis, By Therapies, 2016-2028 (US$ Bn)
12.3.3.3. Rest of Middle East and Africa Porokeratosis, By End-User, 2016-2028 (US$ Bn)

13. Company Profiles
13.1. Coherent Inc.
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2021)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Alma Lasers
13.3. Almirall
13.4. Allergan
13.5. Pfizer
13.6. Lumenis
13.7. Coty Inc.
13.8. Cutera, Bioness Inc.
13.9. Biogen
13.10. PhotoMedex Inc.
13.11. Valeant Pharmaceuticals, Hologic Inc.
13.12. IPG Photonics Corporation
13.13. IRIDEX Corp.
13.14. Hoffman-La Roche Ltd.
13.15. Biolase Inc.
13.16. Angiodynamics Inc.
13.17. Beiersdorf AG

List of Figures
FIG. 1 Global Porokeratosis Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Porokeratosis Market Segmentation
FIG. 4 Global Porokeratosis Market, by Therapies, 2021 (US$ Bn)
FIG. 5 Global Porokeratosis Market, by End-User, 2021 (US$ Bn)
FIG. 6 Global Porokeratosis Market, by Geography, 2021 (US$ Bn)
FIG. 7 Attractive Investment Proposition, by Therapies, 2021
FIG. 8 Attractive Investment Proposition, by End-User, 2021
FIG. 9 Attractive Investment Proposition, by Geography, 2021
FIG. 10 Global Market Share Analysis of Key Porokeratosis Market Manufacturers, 2021
FIG. 11 Global Market Positioning of Key Porokeratosis Market Manufacturers, 2021
FIG. 12 Global Porokeratosis Market Value Contribution, By Therapies, 2021 & 2028 (Value %)
FIG. 13 Global Porokeratosis Market, by Topical 5- fluorouracil, Value, 2016-2028 (US$ Bn)
FIG. 14 Global Porokeratosis Market, by Topical Vitamin D, Value, 2016-2028 (US$ Bn)
FIG. 15 Global Porokeratosis Market, by Imiquimod, Value, 2016-2028 (US$ Bn)
FIG. 16 Global Porokeratosis Market, by Retinoids, Value, 2016-2028 (US$ Bn)
FIG. 17 Global Porokeratosis Market, by Cryotherapy, Value, 2016-2028 (US$ Bn)
FIG. 18 Global Porokeratosis Market, by Laser Therapy, Value, 2016-2028 (US$ Bn)
FIG. 19 Global Porokeratosis Market, by Others, Value, 2016-2028 (US$ Bn)
FIG. 20 Global Porokeratosis Market Value Contribution, By End-User, 2021 & 2028 (Value %)
FIG. 21 Global Porokeratosis Market, by Hospitals, Value, 2016-2028 (US$ Bn)
FIG. 22 Global Porokeratosis Market, by Clinics, Value, 2016-2028 (US$ Bn)
FIG. 23 Global Porokeratosis Market, by Diagnostic Centres, Value, 2016-2028 (US$ Bn)
FIG. 24 Global Porokeratosis Market, by Research and academic Institutes, Value, 2016-2028 (US$ Bn)
FIG. 25 U.S. Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 26 Canada Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 27 Germany Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 28 France Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 29 U.K. Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 30 Italy Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 31 Spain Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 32 Rest of Europe Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 33 China Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 34 Japan Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 35 India Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 36 South Korea Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 37 Southeast Asia Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 38 Rest of Asia Pacific Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 39 Latin America Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 40 Brazil Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 41 Mexico Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 42 Rest of Latin America Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 43 Middle East & Africa Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 44 GCC Countries Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 45 South Africa Porokeratosis Market, 2016-2028 (US$ Bn)
FIG. 46 Rest of Middle East and Africa Porokeratosis Market, 2016-2028 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Porokeratosis Market
TABLE 2 Global Porokeratosis Market, by Competitive Benchmarking, 2021
TABLE 3 Global Porokeratosis Market, by Geographical Presence Analysis, 2021
TABLE 4 Global Porokeratosis Market, by Key Strategies Analysis, 2021
TABLE 5 Global Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 6 Global Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 7 Global Porokeratosis Market, by Geography, 2016-2028 (US$ Bn)
TABLE 8 North America Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 9 North America Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 10 North America Porokeratosis Market, by Country, 2016-2028 (US$ Bn)
TABLE 11 US Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 12 US Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 13 Canada Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 14 Canada Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 15 Europe Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 16 Europe Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 17 Europe Porokeratosis Market, by Country, 2016-2028 (US$ Bn)
TABLE 18 Germany Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 19 Germany Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 20 France Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 21 France Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 22 UK Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 23 UK Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 24 Italy Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 25 Italy Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 26 Spain Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 27 Spain Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 28 Rest of Europe Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 29 Rest of Europe Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 30 Asia Pacific Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 31 Asia Pacific Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 32 Asia Pacific Porokeratosis Market, by Country, 2016-2028 (US$ Bn)
TABLE 33 China Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 34 China Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 35 Japan Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 36 Japan Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 37 India Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 38 India Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 39 South Korea Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 40 South Korea Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 41 South East Asia Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 42 South East Asia Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 43 Rest of Asia Pacific Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 44 Rest of Asia Pacific Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 45 Latin America Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 46 Latin America Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 47 Latin America Porokeratosis Market, by Country, 2016-2028 (US$ Bn)
TABLE 48 Brazil Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 49 Brazil Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 50 Mexico Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 51 Mexico Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 52 Rest of Latin America Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 53 Rest of Latin America Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 54 Middle East and Africa Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 55 Middle East and Africa Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 56 Middle East and Africa Porokeratosis Market, by Country, 2016-2028 (US$ Bn)
TABLE 57 GCC Countries Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 58 GCC Countries Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 59 South Africa Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 60 South Africa Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)
TABLE 61 Rest of Middle East and Africa Porokeratosis Market, by Therapies, 2016-2028 (US$ Bn)
TABLE 62 Rest of Middle East and Africa Porokeratosis Market, by End-User, 2016-2028 (US$ Bn)

Frequently Asked Questions

How does COVID-19 Impact the global Porokeratosis market?

The global Porokeratosis market is expected to be impacted significantly by COVID-19.

Which is the leading market for Porokeratosis?

North America accounted for the highest share in the global Porokeratosis market in value.

What are the key drivers for the growth of the Porokeratosis market?

The global porokeratosis market will grow for various reasons, such as rising laser therapy demand, an increase in kidney transplant cases, better reimbursement laws in developed countries, rising research expenses, and rising competition among market traders.

Which is the major therapies segment in Porokeratosis Market?

The laser therapy segment had a major share in 2021, with more than 30% of the market revenue share.

Which is the major application segment in Porokeratosis Market?

The hospital segment had a major share in 2021, with more than 30% of the market revenue share.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –